Built in Gurugram.For Indian clinical research.
After years running trials on imported tools that were not priced for rupee budgets, did not reference Schedule Y, and were not engineered for non-metro site connectivity, the conclusion was straightforward: India’s clinical research community needed an EDC built for it. So we built one.
Indian clinical research teams spend a disproportionate share of their time as integrators — adopting eClinical platforms priced in USD, transcribing data from paper CRFs at non-metro sites, and stitching together vendor portals that were not designed for Indian regulatory or operational realities.
A unified platform shifts that calculus. When capture, management, quality, compliance, safety, and closeout share a single trial data model and a single audit trail — with all personal data resident in India — the work between systems collapses. Bioequivalence studies start in days. CDSCO submission packs assemble from the same data the trial captured. Site coordinators work from one login.
Our mission: intelligence in every phase of the trial, on one platform, built in India.
The principles behind the platform.
Unify, don't bolt on
Every feature earns its place in one data model. We say no to integrations that should never have been necessary in the first place.
Trials are about people
Behind every volunteer record is a participant. Less friction for site coordinators in tier-2 cities means better data and better care.
Compliance is a foundation
Audit trails, Indian GCP validation, and DPDP-compliant data handling aren't features we sell — they're the ground the whole platform stands on.
Jahnavi Rohil, Co-Founder & CEO.
The fastest path to understanding Trialion is a direct conversation. No SDR queue. No qualification call. The founder’s number, below.
See what one platform looks like.
The most direct path to understanding Trialion is to watch your own bioequivalence or Phase II study run on it.